Rimantadine

This classification denotes an antiviral agent with the molecular formula C12H21N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0T2EF4JQTU, chemically known as 1-adamantanemethylamine, .alpha.-methyl-, hydrochloride but generally known as rimantadine, which bears US NIH Compound Identifier 5071. European Medicines Agency schedules Rimantadine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10320MIG. The term RIMANTADINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). World Health Organization schedules rimantadine in its Anatomical Therapeutic Chemical (ATC) Classification. RIMANTADINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rimantadine under HS 29213099 and SITC 51453. As of Q4 2014, RIMANTADINE remains the US FDA Preferred Term for this commodity. Rimantadine bears US NLM identifiers UMLS ID C0035629 and NCI Concept Code C61927. SMILES: NC(C12CC3CC(C2)CC(C1)C3)C.